BIOGEN INC. Interest Expense 2008-2026 | BIIB
Beta
What is interest expense?
Interest expense represents the cost of borrowing money, including interest paid on bonds, loans, and other debt obligations.
What is BIOGEN INC.'s current interest expense?
BIOGEN INC. (BIIB) annual interest expense for 2025 was $267.5M, a 6.87% increase from 2024. BIOGEN INC. interest expense for the quarter ending March 31, 2026 was $67.6M.
What was BIOGEN INC.'s interest expense in 2024?
BIOGEN INC. annual interest expense for 2024 was $250.3M, a 1.38% increase from 2023.
What was BIOGEN INC.'s interest expense in 2023?
BIOGEN INC. annual interest expense for 2023 was $246.9M, a 0.12% increase from 2022.
What is BIOGEN INC.'s 5-year interest expense CAGR?
BIOGEN INC. interest expense grew at a compound annual growth rate (CAGR) of 3.75% from FY2020 to FY2025, going from $222.5M to $267.5M over 5 years.
Interest Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+3.8%
FY2020
$222.5M
→
FY2025
$267.5M
080910111213141516171819202122232425
5 years selected
Interest Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $267.5M | +6.9% | 10-K |
| FY2024 | $250.3M | +1.4% | 10-K |
| FY2023 | $246.9M | +0.1% | 10-K |
| FY2022 | $246.6M | -2.8% | 10-K |
| FY2021 | $253.6M | +14.0% | 10-K |
| FY2020 | $222.5M | +18.7% | 10-K |
| FY2019 | $187.4M | -6.6% | 10-K |
| FY2018 | $200.6M | -20.0% | 10-K |
| FY2017 | $250.8M | -3.5% | 10-K |
| FY2016 | $260.0M | +172.3% | 10-K |
| FY2015 | $95.5M | +223.7% | 10-K |
| FY2014 | $29.5M | -7.5% | 10-K |
| FY2013 | $31.9M | -12.6% | 10-K |
| FY2012 | $36.5M | +10.6% | 10-K |
| FY2011 | $33.0M | -8.6% | 10-K |
| FY2010 | $36.1M | +0.8% | 10-K |
| FY2009 | $35.8M | -31.2% | 10-K |
| FY2008 | $52.0M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →